ArticleAntioxidants (Basel, Switzerland)2021

Does Empagliflozin Modulate Leukocyte-Endothelium Interactions, Oxidative Stress, and Inflammation in Type 2 Diabetes?

Francisco Canet et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.